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with or without MICU1. This ratio is
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mitochondrial Ca2+ uptake phenotypes in
the heart and liver.
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Mitochondrial Ca2+ uptake through the Ca2+ uni-
porter supports cell functions, including oxidative
metabolism, while meeting tissue-specific calcium
signaling patterns and energy needs. The molecular
mechanisms underlying tissue-specific control of
the uniporter are unknown. Here, we investigated a
possible role for tissue-specific stoichiometry be-
tween the Ca2+-sensing regulators (MICUs) and
pore unit (MCU) of the uniporter. Low MICU1:MCU
protein ratio lowered the [Ca2+] threshold for Ca2+
uptake and activation of oxidative metabolism but
decreased the cooperativity of uniporter activation
in heart and skeletal muscle compared to liver. In
MICU1-overexpressing cells, MICU1 was pulled
down by MCU proportionally to MICU1 overexpres-
sion, suggesting that MICU1:MCU protein ratio
directly reflected their association. Overexpressing
MICU1 in the heart increased MICU1:MCU ratio,
leading to liver-like mitochondrial Ca2+ uptake
phenotype and cardiac contractile dysfunction.
Thus, the proportion of MICU1-free and MICU1-
associated MCU controls these tissue-specific
uniporter phenotypes and downstream Ca2+ tuning
of oxidative metabolism.INTRODUCTION
Mitochondrial Ca2+ uptake provides a fundamental input to the
control of oxidative metabolism and contributes to cell-sur-
vival-regulating mechanisms. It is primarily driven by the
membrane potential (DJm) and is mediated by an electrogenic
uniport, referred to as ‘‘Ca2+ uniporter’’ (mtCU). Tissue-specific
differences in the Ca2+ uptake kinetics have been noted for
some time and attributed to tissue-specific alternative Ca2+ up-
take mechanisms. These mechanisms either had a phenomeno-
logical definition, such as rapid uptake mode, or were linked toThis is an open access article under the CC BY-Nryanodine receptors or uncoupling proteins (Buntinas et al.,
2001; De Stefani et al., 2016). Recently, comparison of IMiCa in
different tissues revealed great differences in the current density
(Fieni et al., 2012). Among tissues with high amounts of mito-
chondria that strongly depend on oxidative metabolism, liver,
muscle, and heart showed both qualitative and quantitative dif-
ferences in Ca2+ uptake and currents (Buntinas et al., 2001; Fieni
et al., 2012). These differences are particularly interesting in the
context of the distinct frequencies of calcium signals that hepatic
and cardiac mitochondria cope with. Specifically, in resting he-
patocytes, cytoplasmic Ca2+ ([Ca2+]c) is steadily low, and upon
stimulation, [Ca2+]c oscillations are induced with a cycle time of
20 s or more (Hajno´czky et al., 1995; Robb-Gaspers et al.,
1998). By contrast, in murine cardiomyocytes, [Ca2+]c constantly
oscillate with resting and stimulated cycle times between
0.15 and 0.08 s. In hepatocytes, each [Ca2+]c spike propagates
to mitochondria individually, whereas in mouse cardiomyocytes,
mitochondria likely take up little Ca2+ from a single [Ca2+]c spike
and integrate spikes of varying frequencies to control the
Ca2+ response (Griffiths and Rutter, 2009).
The major mtCU-forming proteins have been identified,
including the pore, MCU (Baughman et al., 2011; Chaudhuri
et al., 2013; De Stefani et al., 2011); its dominant-negative
form, MCUb (Raffaello et al., 2013); a scaffold, EMRE (Sancak
et al., 2013); and helix-loop-helix structural domain (EF-hand)
containing Ca2+-sensitive regulators, MICU1 (Csorda´s et al.,
2013; Mallilankaraman et al., 2012a; Perocchi et al., 2010;
Wang et al., 2014) and MICU2 (Kamer andMootha, 2014; Patron
et al., 2014; Plovanich et al., 2013). To date, a MICU complex
(a hetero/homo-dimer of MICU1 and MICU2) appears to deter-
mine both the threshold and cooperative activation of the
mtCU by Ca2+ (Csorda´s et al., 2013; Hung et al., 2014; Patron
et al., 2014; Perocchi et al., 2010; Plovanich et al., 2013).
MCU and MICU1 both show tissue-specific mRNA expres-
sion, which is particularly low for MICU1 in cardiac muscle (De
Stefani et al., 2011; Mallilankaraman et al., 2012b; Plovanich
et al., 2013). Whole-body MCU knockout is either embryonic le-
thal or unexpectedly irrelevant for normal development, depend-
ing upon the mouse strain (Pan et al., 2013). We have shown that
MICU1 knockout mice die perinatally, and deletion of MICU1 in
the liver interferes with survival and tissue regeneration afterCell Reports 18, 2291–2300, March 7, 2017 ª 2017 2291
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
partial hepatectomy (Antony et al., 2016). Loss-of-function hu-
man MICU1 mutations have also been linked to neurological
and skeletal muscle disease (Logan et al., 2014). MICU1/2
have been shown to account for the non-linear Ca2+ dependence
of mtCU-mediated Ca2+ uptake, but their involvement in the
in vivo tissue-specific differences in the mtCU Ca2+ sensitivity
is still unclear. Here, we tested whether protein levels of MICUs
and MCU and their stoichiometry could control mitochondrial
Ca2+ uptake in accordance with tissue-specific physiological
needs. In terms of integration of mitochondrial Ca2+ uptake
with tissue-specific functions, the control of IMiCa by [Ca
2+]c is
highly relevant but is difficult to study at low [Ca2+]. The lowest
[Ca2+] tested by Fieni et al. (2012) was 50 mM, which is orders
of magnitude higher than the resting [Ca2+]c. A recent modeling
study emphasized that cardiac and liver mitochondria display a
common relationship for the [Ca2+]c dependence of mitochon-
drial Ca2+ uptake (Williams et al., 2013), but the submicromolar
range of the curve fit does not seem to be reliable. Therefore,
we decided to systematically quantify the [Ca2+]c dependence
of mitochondrial Ca2+ fluxes and the uniporter protein constitu-
ents in different tissues derived from the same donor mouse.
RESULTS
Distinct Ca2+ Dependence of Ca2+ Uptake and Oxidative
Metabolism in Heart and Liver
Wefirst focused on cardiac and livermitochondria and evaluated
mtCU-mediated mitochondrial Ca2+ uptake fluorometrically in
suspensions of isolated mitochondria by measuring the ruthe-
nium red (RuRed)-sensitive clearance of Ca2+ added to the cyto-
plasmic medium. To better isolate the mitochondrial Ca2+ influx,
these experiments were done in the presence of sarco/endo-
plasmic reticulum Ca2+-ATPase (SERCA) inhibitor thapsigargin
(Tg) and the mitochondrial Na+-Ca2+ exchanger blocker
CGP37157. Interestingly, in response to submicromolar [Ca2+]c
increases, liver mitochondria displayed almost no Ca2+ clear-
ance, whereas heart mitochondria showed a strong decrease
in [Ca2+]c (Figure 1A). This suggests that the [Ca
2+] threshold of
the mtCU can be very low for certain tissues, such as heart.
To assess a potential effect on oxidativemetabolism, we evalu-
ated theNAD(P)Hautofluorescenceasameasureof the activation
of the Ca2+-sensitive matrix dehydrogenases. The Ca2+ uptake
observed at low [Ca2+]c in heart mitochondria was associated
with a significant increase in NAD(P)H, whereas no changes in
NAD(P)Hwereobserved in livermitochondria under thesamecon-
ditions (Figure 1B). When exposed to higher free [Ca2+]c up to
15 mM, a rapid mitochondrial Ca2+ clearance was measured for
both tissues, with liver mitochondria taking up Ca2+ faster than
heart mitochondria (Figure 1C). Simultaneous recordings of
[Ca2+]c and DJm showed only small depolarization during Ca
2+
uptake in cardiac mitochondria, indicating that the uptake was
not limited by the driving force (Figure 1D). At this higher [Ca2+]c
exposure, NAD(P)H response was higher in liver mitochondria
than heartmitochondria (Figure 1B; 8.03%± 1.06% in liver versus
3.27% ± 0.90% in heart; p < 0.05). Both the mitochondrial depo-
larization and the NAD(P)H response to Ca2+ were prevented by
RuRed (n = 3; data not shown), confirming that these changes
were downstream of mitochondrial Ca2+ uptake.2292 Cell Reports 18, 2291–2300, March 7, 2017To better characterize the [Ca2+]c dependence of the hepatic
and cardiac mitochondrial Ca2+ uptake, we constructed a
[Ca2+]c dose response for the initial Ca
2+ uptake rates (Figure S1)
and for the fractional uptake (Figure 1E). In both presentations,
the low end reached lower and the high end higher values for liver
mitochondria, suggesting a higher mtCU [Ca2+]c threshold and
higher maximal activity. Double logarithmic plots of the initial
Ca2+ uptake rates against [Ca2+]c confirmed a higher slope in
liver than in heart (Figure 1F; 2.67 ± 0.09 versus 1.48 ± 0.12;
p < 0.05). Thus, mitochondrial Ca2+ uptake displays distinct
Ca2+ dependence between heart and liver and occurs already
at submicromolar [Ca2+]c in heart mitochondria.
Liver, Heart, andMuscleMitochondria ShowDifferential
Activation of Mitochondrial Ca2+ Uptake by Ca2+, Linked
to Their Distinct MICUs and MCU Expression Profiles
To further address the regulation of themtCU in different tissues,
we quantified the RuRed-sensitive 45Ca2+ (45Ca) sequestration
by mitochondria isolated from heart, liver, and skeletal muscle.
In response to a submicromolar Ca2+ bolus (660 nM), liver mito-
chondria displayed linear uptake kinetic for at least 30 s with a
hardly detectable rate, whereas cardiac and even more the skel-
etal muscle mitochondria showed faster 45Ca accumulation (Fig-
ures 2A and 2C), demonstrating a very low threshold of activation
for the mtCU in the latter tissues. Differently, in response to
12 mM [Ca2+], 45Ca uptake by liver mitochondria was faster
than that by heart mitochondria, whereas uptake by skeletal
muscle mitochondria was the fastest (Figures 2B and 2C).
RuRed effectively abolished 45Ca accumulation by mitochondria
isolated from each tissue, validating the specificity of the uptake
through the mtCU. Double logarithmic plots of the initial Ca2+
accumulation (15 s; RuRed sensitive uptake) against [Ca2+]c indi-
cated a higher threshold for liver than heart or skeletal muscle
mitochondria (Figure 2D). The plot for liver mitochondria also
showed a higher slope, confirming different levels of positive
cooperativity for [Ca2+]-dependent activation of mtCU in the
different tissues (liver: 1.68 versus heart: 1.02 and muscle:
0.87; p < 0.05), as shown by fluorescence (Figure 1F).
We speculated that the relative abundance of MICUs and
MCU proteins might account for the tissue-specific mitochon-
drial Ca2+ uptake phenotypes in these three tissues. Analysis
of the protein level of the components of the mtCU in the mito-
chondria used for the Ca2+ transport measurements showed
higher MICU1 abundance in mouse liver and skeletal muscle
versus heart mitochondria, whereas MICU2 appeared relatively
high in heart mitochondria. MCU was slightly but significantly
lower in heart than liver and much higher in skeletal muscle mito-
chondria (Figures 3A and 3B). Altogether, these results support a
distinct profile for both MICUs and MCU protein expression in
liver, heart, and skeletal muscle.
The high amount of MCU correlates directly with the fast
45Ca uptake in skeletal muscle. However, the lower amount of
MCU in heart versus liver could not account for the faster
45Ca uptake at the submicromolar range in heart. Also, the
[Ca2+]c dependency was similar in heart and skeletal muscle
(see slopes in Figure 2D). To test whether the stoichiometry,
i.e., the quantitative abundance of MICUs andMCUmight deter-
mine the different mitochondrial Ca2+ uptake profiles in these
Figure 1. Cardiac Mitochondria Display Low-Threshold and Less Cooperative Activation of Ca2+ Uptake and Oxidative Metabolism
Compared to Liver Mitochondria
(A) Time courses of the mitochondrial clearance of the [Ca2+]c rise upon addition of a 3 mM CaCl2 bolus (3Ca) in suspensions of liver (black) and heart (red)
mitochondria, with and without RuRed (3 mM).
(B) NAD(P)H autofluorescence level (expressed as a% by calibration; see Experimental Procedures) measured after a CaCl2 bolus of 3 or 30 mM (3Ca or 30Ca) in
heart and liver mitochondria.
(C) Mitochondrial clearance of [Ca2+]c elevations induced by 50 mM CaCl2 addition.
(D) DJm measured with tetramethylrhodamine, methyl ester (TMRM). TMRM is used in de-quench mode; thus, the direction of polarization is downward. Note
that heart mitochondria are the more polarized.
(E) [Ca2+]c dose response for the initial mitochondrial uptake of different Ca
2+ boluses in mouse liver (black) and heart (red) mitochondria. The CaCl2 doses added
were (in mM) 3, 5, 7, 10, 20, and 50 (n = 6 mice). A sigmoidal fit is displayed for each. x axis displays the measured peak [Ca2+]c.
(F) Double logarithmic plot of the initial rates of Ca2+ uptake against the measured peak [Ca2+]c. Slope of each linear fit is indicated. Slopes calculated for both
[Ca2+]c clearance and
45Ca uptake (Figure 2D) show similar tissue-specific pattern, but for unclear reasons, the absolute values are consistently higher for the
[Ca2+]c clearance.
Data are presented as mean ± SEM; n = 3–4. See also Figure S1.
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Figure 2. Liver, Heart, and Skeletal Muscle Mitochondria Show Distinct Regulation of Mitochondrial 45Ca2+ Uptake
(A and B) Representative time courses of 45Ca2+ accumulation in isolated liver, heart, and skeletal mitochondria in presence or absence of RuRed (3 mM) after
elevating [Ca2+]c moderately (to 660 nM; A) or strongly (to 12 mM; B) by the addition of a pre-titrated Ca
2+ bolus. Data are representative of n = 4 independent
experiments with triplicates (mean ± SEM).
(C) Mean values of the calculated 45Ca accumulated from traces similar to (A) and (B), against three ranges of free [Ca2+]c.
(D) Double logarithmic plot of the RuRed-sensitive 45Ca accumulated against the free [Ca2+]c 15 s after the addition. n = 4 independent experiments with trip-
licates.tissues, we calculated for the three tissues in each mouse
the protein ratios among MICU1, MICU2, and MCU (Figures
3C–3E) and then the ratio of the 45Ca uptake at low and high
[Ca2+]c, which is higher when both threshold and cooperativity
are low (Figure 3F). Only the MICU1:MCU ratio showed a com-
plementing pattern with the mitochondrial Ca2+ uptake pheno-
type (Figures 3E and 3F). Indeed, both heart and muscle mito-
chondria, which displayed lesser threshold and cooperativity of
mtCU activation than liver mitochondria (Figure 3F), had a low
MICU1:MCU ratio (Figure 3E), whereas their MICU1:MICU2 (Fig-
ure 3C) and MICU2:MCU ratios (Figure 3D) were clearly oppo-
site. Thus, the mitochondrial Ca2+ uptake behavior for a popula-
tion of mitochondria within a tissue seems to be dictated by the
relative abundance of MICU1 and MCU.
To test the relevance of other components of the mtCU in its
[Ca2+]-dependent regulation, the protein abundance of another
mtCU regulator, MICU3, as well as EMRE was evaluated in liver,
heart, and muscle mitochondria (Figure S2A). MICU3 was
detectable only in skeletal muscle mitochondria, and EMRE level
followed the MCU expression profile, i.e., significantly higher
levels in skeletal muscle than heart and liver mitochondria (Fig-2294 Cell Reports 18, 2291–2300, March 7, 2017ure S2B). Thus, neither MICU3 nor EMRE correlated with the
tissue-specific [Ca2+] dependence of the mtCU. The lack of a
reliable antibody precluded quantification of MCUb, but this
protein is devoid of a known Ca2+-binding motif. Recently, a
MICU1 splice variant, MICU1.1, was identified specifically in
skeletal muscle as a positive regulator of the mtCU in the entire
physiological range of [Ca2+]c (Vecellio Reane et al., 2016) and so
could have contributed to the high mtCU Ca2+ transport activity
in skeletal muscle. Notably, bothMICU1.1 andMICU1 are recog-
nized by theMICU1 antibody used by Vecellio Reane et al. (2016)
and us, and the two isoforms are undistinguishable in western
blot due to their close molecular weight. Collectively, these
data seem to indicate a role for the MICU1:MCU ratio in vivo
in the physiological tissue-specific control of mitochondrial
Ca2+ uptake.
MICU1:MCU Protein Expression Ratio Correlates
Directly with MICU1 to MCU Association
An outstanding point remains whether the changes in MICU1
and MCU expression affect their association. Unfortunately,
the lack of a reliable antibody for immunoprecipitation (IP) of
Figure 3. MICU1 to MCU Protein Expression Ratio Correlates Directly with MICU1 to MCU Association to Control the Threshold and
Cooperative Activation of Mitochondrial Ca2+ Uptake in Tissues
(A) Representative immunoblotting in reducing conditions of MICU1, MICU2, MCU, and Hsp70 (mitochondrial loading control) in mice liver, heart, and skeletal
muscle mitochondrial lysates.
(B) Relative protein level of MICU1, MICU2, and MCU is displayed in the bar graph for each protein relative to Hsp70 and normalized to liver mitochondria.
(C–E) Protein ratios of MICU1 to MICU2 (C), MICU2 to MCU (D), and MICU1 to MCU (E) calculated individually for each mouse.
(F) Ratio between the Ca2+ accumulated at low [Ca2+]c and at high [Ca
2+]c (from Figure 2C) for each experiment.
Mean ± SEM; n = 4; *p < 0.05.
(G) HEK cells were co-transfected withMCU-FLAGand different levels of MICU1-HA to generate differentMICU1 toMCU ratios. MCU-FLAG andMICU1HAwere
co-immunoprecipitated either with specific FLAG-agarose beads or HA-agarose beads.
(H) MICU1 to MCU ratio was calculated for the input and after the MCU-FLAG IP and normalized so that the values at the highest MICU1 to MCU ratio in the input
were set to 1 for each experiment, indicated by the different shaped dot plots (n = 5). The linear fit indicates that the higher the MICU1 expression, the higher the
MICU1 pulled down by MCU.
(I) Similar calculations were performed as in (H) for the MICU1-HA IP (n = 3). The linear fit shows that the amount of MCU units bound to MICU1 is not changed by
increasing the MICU1 expression.
See also Figures S2 and S3.endogenous MICU1 and MCU precluded co-IP experiments in
mouse tissues. Therefore, co-IP of MCU-FLAG and varying
amounts of MICU1-hemagglutin (HA) co-transfected to
MICU1-knockout (KO) HEK cells was performed to establish
different MICU1:MCU ratios. Based on the MCU-FLAG IP,
increasing the MICU1 protein level (and so the MICU1:MCU ra-tio) led to an essentially linear increase in the MICU1:MCU ratio
in the IP, indicating a direct correlation between the MICU1 to
MCU expression and association (Figures 3G and 3H). Further-
more, the MICU1-HA IP showed that the MCU bound per
MICU1 is unchanged by different levels of MICU1 expression
(Figures 3G–3I), suggesting that, in a broad range of MICU1Cell Reports 18, 2291–2300, March 7, 2017 2295
Figure 4. Increasing the MICU1 to MCU Ratio in the Heart Leads to a Liver-like mtCU Phenotype
(A) mRNA level of human MICU1 (hMICU1) and mouse MICU1, MICU2, and MCU in AAV9-Luc (red) and AAV9-MICU1 (black) heart 3 weeks after the virus
injection. The relative mRNA is reported using b-actin as a reference and normalized to the AAV9-Luc heart (mean ± SEM; n = 4; *p < 0.05 versus AAV9-Luc).
(B) Protein expression of MICU1, MICU2,MCU, and Hsp70 in heart mitochondrial lysates fromAAV9-Luc and AAV9-MICU1 3weeks after injection. Level for each
protein is shown relative to the loading control Hsp70 and normalized to AAV9-Luc heart mitochondria (mean ± SEM; n = 4; *p < 0.05).
(legend continued on next page)
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expression, MICU1 quantitatively binds MCU and some uni-
porter complexes do not have MICU1. To summarize, MCU
pulled down MICU1 proportionally to its relative abundance
whereas MICU1 at various expression levels pulled down steady
amounts of MCU, suggesting that MICU1:MCU ratio controls a
binary balance between uniporter complexes with or without
MICU.
Because the quantitative association of MICU1 and MCU was
testable only in vitro, we decided to also test the control of mito-
chondrial Ca2+ uptake by changes in expression of MICU1 and
MCU in cell culture. To this end, we either overexpressed MCU
or silenced MICU1 in HeLa cells, with both resulting in reduced
MICU1/2:MCU ratio (Figure S3A). To test whether the increased
abundance of mtCUs without MICU1 would decrease the
mtCU’s [Ca2+]c threshold, we evaluated in intact cells [Ca
2+]c
and [Ca2+]m during store-operated Ca
2+ entry when most mito-
chondria respond to the bulk [Ca2+]c increase. Both MCU over-
expression and MICU1 silencing accelerated the [Ca2+]m rise
as displayed by the shorter lag between the [Ca2+]c and
[Ca2+]m increases (Figure S3B) and shorter coupling time (ctrl:
28.9 ± 1.7 s versus MCU: 21.5 ± 1.0 s; p < 0.05). In addition,
as revealed by [Ca2+]m versus [Ca
2+]c plots, lower [Ca
2+]c was
sufficient to trigger a [Ca2+]m rise upon both MCU overexpres-
sion and MICU1 silencing (Figure S3B, lower). Thus, both MCU
overexpression and MICU1 silencing cause lesser thresholding
of the mtCU phenotype in intact HeLa cells.
To confirm the effect of the MICUs to MCU ratio more directly
on mitochondrial Ca2+ uptake, we next measured the [Ca2+]m in
permeabilized cells using a ratiometric Ca2+ probe, furaFF. Com-
partmentalized furaFF displayed mitochondrial localization in
permeabilized HeLa cells as shown by colocalization with
TMRE or mitochondria-targeted GFP (Figure S3C). When Ca2+
was added, the increase in the furaFF ratio was abolished by
RuRed (Figure S3D), validating that the compartmentalized
furaFF signal reported [Ca2+]m. Cells overexpressing MCU dis-
played a significant elevation of their resting [Ca2+]m compared
to Ctrl, which was prevented by RuRed (Figures S3D and S3F).
After a Ca2+ pulse (1.5 mM), a higher initial rate of RuRed-sensi-
tive [Ca2+]m rise was observed inMCU-overexpressing cells than
in Ctrl cells (Figure S3D). Similar findings, i.e., an increased
resting [Ca2+]m and an accelerated [Ca
2+]m rise, were also
observed in MICU1-silenced HeLa cells (Figures S3E and
S3F). Together, these results suggest that decreasing the
MICU1/2:MCU ratio lowers the apparent [Ca2+]c threshold of
the mtCU-mediated mitochondrial Ca2+ uptake in HeLa cells
and thus support the idea that the threshold can be tuned also
in vitro via shifting the balance between MCU complexes with
and without MICU1. Among the three MICU isoforms, MICU3(C) Comparison of the initial mitochondrial Ca2+ uptake at low and high [Ca2+
AAV9-MICU1 heart mitochondria. Data are expressed as a percentage of he
mitochondria (n = 4–6; *p < 0.05 versus respective heart).
(D) Double logarithmic plot of the initial rates of Ca2+ uptake against the measure
(E) Adaptation of mitochondrial decoding to the different temporal patterns of [Ca
MCU in mouse liver and heart. In hepatocytes, the high MICU1 to MCU ratio and s
threshold and cooperativity of their uniporters, allow rapid and highly effective pr
display a lowMICU1 toMCU ratio and thus a higher abundance ofMICU1-freeMC
a more continuous [Ca2+]m increase, the magnitude of which depends on the fre
See also Figure S4 and Table S1.is practically absent in HeLa cells, whereas both MICU1 and
MICU2 showed similar changes in the above experiments, leav-
ing the individual contribution of the two proteins unseparated.
Reprogramming Mitochondrial Ca2+ Uptake by
Perturbing MICU1 in Heart and Liver
Could mitochondrial Ca2+ uptake be reprogrammed in liver and
heart by perturbing the MICU:MCU ratio? To determine the ef-
fect of MICU1 overexpression in the heart, mice were infected
by tail-vein injection with an adeno-associated virus of serotype
9 (AAV9), including either the luciferase gene or the human
MICU1 gene (AAV9-Luc and AAV9-MICU1). Three weeks after
injection, the human MICU1 mRNA level was increased in the
heart of AAV9-MICU1 mice without a significant change in
MCU, MICU2, and MCUb (Figure 4A; Table S1). The increased
MICU1 (but not MICU2 or MCU) protein expression was
confirmed by immunoblotting (Figure 4B). As to the quantitative
relationship between MICU and MCU, the AAV9-MICU1 mouse
heart displayed a 2.6-fold increase of the MICU1:MCU and a
1.3-fold augmentation of the MICU2:MCU ratio (Figure S4A).
We then assessed the effect of MICU1 overexpression on the
cardiac mitochondrial Ca2+ uptake. AAV9-MICU1 heart mito-
chondria took up less Ca2+ at submicromolar [Ca2+]c but dis-
played faster Ca2+ clearance at R10 mM [Ca2+]c compared to
AAV9-Luc Ctrl mitochondria (Figures 4C, S4B, and S4C). More-
over, no limitation in the DJm was observed between AAV9-Luc
and AAV9-MICU1 heart mitochondria to explain the Ca2+ uptake
rate difference at high [Ca2+]c (Figure S4D). Comparison of the
initial mitochondrial Ca2+ uptake between heart versus liver
and AAV9-Luc versus AAV9-MICU1 heart mitochondria showed
a significantly higher threshold at low [Ca2+]c and a significantly
higher uptake at high [Ca2+]c in AAV9-MICU1 heart mitochondria
and liver mitochondria compared to normal heart mitochondria
(Figure 4C). It is worth noting that liver mitochondria displayed
a greater uptake than MICU1-overexpressing heart mitochon-
dria at high [Ca2+]c, which might be explained by the lower
MCUb in liver (see mRNA in Table S1). Double logarithmic
plot also revealed an increased cooperative activation in the
AAV9-MICU1 heart mitochondria, as evidenced by the higher
slope (Figure 4D; 2.52 ± 0.08 in AAV9-MICU1 versus 1.88 ±
0.06 in AAV9-Luc; p < 0.05). Thus, the in vivo strategy to perturb
MICU1 shows that increasing the MICU1:MCU ratio in the heart
led to transition to a liver-like mitochondrial Ca2+ uptake pheno-
type, meaning an increased threshold and cooperativity of the
mtCU activation. This point is further supported by a comple-
mentary experiment, using in vivo silencing of MICU1 in liver,
which demonstrated a lower [Ca2+]c threshold and lesser posi-
tive cooperativity of mitochondrial Ca2+ uptake in association]c in non-infected mouse heart and liver mitochondria and in AAV9-Luc and
art for liver mitochondria and of AAV9-Luc for AAV9-MICU1 mouse heart
d peak [Ca2+]c. Slope of each linear fit is indicated (n = 5).
2+]c signals through the balance between MICU1-associated and MICU1-free
o more abundant MICU1-associated MCU complexes, which lead to both high
opagation of each [Ca2+]c spike to the mitochondria. In cardiomyocytes, which
Uwith low threshold and cooperativity, the [Ca2+]c transients are integrated into
quency of [Ca2+]c oscillations.
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with the decrease in the MICU1:MCU ratio (Antony et al., 2016;
Csorda´s et al., 2013). Collectively, these results strongly support
a specific and major role for the MICU1:MCU ratio and thus the
relative abundance of MICU1-associated and MICU1-free
uniporters in the tissue-specific regulation of mitochondrial
Ca2+ uptake in mice.
Recently, MCU has been shown to be dispensable for base-
line cardiac function but required for the fight-or-flight response
(Kwong et al., 2015; Luongo et al., 2015). We wondered whether
reprogramming of the mitochondrial Ca2+ uptake by MICU1
would affect cardiac physiology. AAV9-MICU1 and AAV9-Luc
mice were subjected to echocardiography: we observed a
significant decrease in both ejection fraction and fractional
shortening (respectively 66% ± 3% versus 57% ± 2% and
36% ± 2% versus 29% ± 1%; AAV9-Luc versus AAV9-MICU1;
p < 0.05; n = 9–10), indicating a contractile impairment in the
AAV9-MICU1 mice. These results suggest that the low MICU1
level in the heart is required to properly decode the cytoplasmic
Ca2+ signals by the mitochondria (Figure 4E) and to optimize
contractile function.
DISCUSSION
Here, we report that the expression of MICU1 relative to MCU
and, in turn, their association into the mtCU complex with or
without MICU1 is central to the tissue-specific differences in
mitochondrial Ca2+ uptake and Ca2+-stimulated oxidative meta-
bolism phenotypes. Specifically, MICU1 to MCU stoichiometry
encodes the differential [Ca2+] dependence between hepatic
and cardiac mitochondria, contributing to the fundamental
mechanism that allows rapid and highly effective propagation
of each [Ca2+]c spike tomitochondria in hepatocytes and a lesser
mitochondrial response to individual [Ca2+]c oscillations in
mouse cardiomyocytes that beat continually at 400–600/min
rate. Thus, our data unravel a mechanism that might be central
to determining spike-to-spike versus slow spike integration
modes of mitochondrial Ca2+ signaling (Figure 4E).
Previous studies have documented differences between
Ca2+ uptake by liver and heart mitochondria (Buntinas et al.,
2001; Williams et al., 2013), which we systematically analyzed
by recording [Ca2+] dependence under identical conditions for
the two tissues. These studies demonstrated that heart mito-
chondria have lesser maximal Ca2+ uptake capacity and less
steep non-linear [Ca2+] dependence than liver mitochondria.
The difference in Ca2+ uptake capacity, which is also supported
by electrophysiology (Fieni et al., 2012), might result from the
relatively high cardiac MCUb expression. As to the differential
[Ca2+] dependence, we speculated that it is likely related to
MICUs because only these mtCU components display EF hand
extramitochondrial Ca2+-sensing modules. Indeed, we demon-
strated that MICU1 protein is scarcely present in the heart.
MICU2, which seems to contribute to the regulation of mtCU
by forming dimers withMICU1 (Kamer andMootha, 2014; Patron
et al., 2014), showed less striking expression level differences
between heart and liver. Strikingly, we could reproduce both car-
diac- and liver-like [Ca2+] dependency patterns in model cells by
altering the MICU1 to MCU stoichiometry. Also, by increasing
MICU1, we could reprogram heart mitochondria to show a liver2298 Cell Reports 18, 2291–2300, March 7, 2017phenotype of [Ca2+] dependency, which led to a contractile
dysfunction. Because the heart still expresses a very low level
of MICU1 protein, it means that there are a few MCU complexes
interacting with MICU1 in the heart, but the balance is strongly
shifted toward the MICU1-free uniporters, resulting in a low-
threshold mitochondrial Ca2+ phenotype. One could wonder
whether different Ca2+ transporters and buffering systems in liver
and heart could also explain the tissue specificity. However, our
Ca2+ uptake experiments were specific for the mtCU (RuRed
validation; inhibition of Ca2+ efflux). Thus, our results support
that the relative abundance of MICU1 and MCU determines
the proportion of mtCU with and without MICU1, which results
in physiological differences in mitochondrial Ca2+ sensing.
The potential physiological and pathophysiological signifi-
cance of the distinct [Ca2+] dependence in heart and liver is
broad. In H9c2 cardiac myotubes that have little spontaneous
activity, we have shown that even a single [Ca2+]c spark can be
propagated to an adjacent mitochondrion to evoke a [Ca2+]m
mark (Pacher et al., 2002), and in rabbit, rat, and guinea pig my-
ocytes that display 400 Hz [Ca2+]c oscillations, beat-to-beat
[Ca2+]m responses have been documented (Andrienko et al.,
2009; Maack et al., 2006; Robert et al., 2001; Trollinger et al.,
2000). However, at the even higher beating frequency of mouse
heart, suppressing the response to individual Ca2+ transients
and integration of frequency fluctuations is practical to avoid
mitochondrial Ca2+ overload. In mouse cardiomyocytes, which
display a low MICU1 to MCU ratio and thus a low threshold
and cooperativity of most of their uniporters, the very short
[Ca2+]c transients are associated with very small mitochondrial
Ca2+ uptake that is integrated into frequency-modulated
[Ca2+]m steady-state shifts rather than [Ca
2+]m oscillations. By
contrast, the high MICU1 and cooperative activation of mtCU
in the liver favors delivery of each individual [Ca2+]c spike to the
mitochondria in hepatocytes (Csorda´s et al., 2013). These differ-
ences are depicted in the schematic of Figure 4E. Interestingly,
heart mitochondria also display a higher NCLX level than liver
mitochondria (data not shown), suggesting that higher mito-
chondrial Ca2+ efflux in heart may be required for preventing
mitochondrial Ca2+ overload.
In summary, our work identifies the MICU1 to MCU ratio as a
physiological regulator of the mitochondrial Ca2+ uptake pheno-
type in tissues, contributing to the tissue-specific decoding of
[Ca2+]c oscillations toward differentially regulating oxidative
metabolism in liver and heart. In light of the recent description
of mitochondrial disease linked to loss-of-function MICU1muta-
tions (Logan et al., 2014), the delicate balance of MICU1 and
MCU likely is important in humans and in a variety of tissues,
including nervous tissue and skeletal muscle.
EXPERIMENTAL PROCEDURES
Detailed protocols are available in the Supplemental Experimental
Procedures.
Animals
Mice were bred by homozygous intercross. Studies were done in accordance
with the Thomas Jefferson University institutional review board guidelines. Fe-
male mice were used for the isolation of liver and heart mitochondria. For
MICU1 overexpression, tail-vein injection was performed on male mice at
10weeks old with 63 1011 genome copies (GCs)/mouse of AAV9-luciferase or
AAV9-MICU1.
Heart, Skeletal Muscle, and Liver Mitochondria Isolation
Mice were euthanized by cervical dislocation. Heart, muscle, and liver mito-
chondria were isolated by differential centrifugations from the same mice.
Live-Cell Imaging and Fluorometric Measurements of Mitochondrial
Ca2+ Uptake, Membrane Potential, and NADH
[Ca2+]m, [Ca
2+]c, and DJm were measured as described (Csorda´s et al., 2013).
NAD(P)H autofluorescence wasmonitored with excitation at 360 nm and emis-
sion at 450 nm,whereas [Ca2+]c was recorded simultaneously with rhod2 using
545 nm excitation and 580 nm emission. Themitochondrial NAD(P)H oxidation
state was calibrated by applying 5 mM rotenone and 2 mM carbonyl cyanide-
4-(trifluoromethoxy)phenylhydrazone (FCCP) at the end of each recording.
Tg and CGP-37157 were present in all measurements.
Measurements of 45Ca Uptake by Isolated Mitochondria
Mitochondria (250 mg/mL) were resuspended in intracellular medium (ICM)
containing 2 mM Tg, 20 mM CGP-37157, and 10 mM EGTA. Mitochondria
were energized by 1mMmalate/pyruvate at 37C. Subsequently, suspensions
were mixed with different amounts of 45Ca in the absence or presence of
RuRed (3 mM). At 15-s and 30-s time points, 100-mL aliquots were stopped
and 45Ca in the mitochondria was quantified as described (Csorda´s et al.,
2013). Free [Ca2+]c was measured separately by fluorometric measurements
using fura2 or furaFF.
Statistical Analysis
Data are expressed as mean ± SEM. Experiments were performed at least
three times in duplicates or more. Statistical analysis was performed using
the Student’s t test, paired t test, or Mann-Whitney rank sum test when
comparing two groups and ANOVA-1 followed by a Student-Newman-Keuls
post hoc test for comparisons between multiple groups.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2017.02.032.
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